News on Shiga-Toxigenic_Escherichia_coli from BioPortfolio.com http://www.BioPortfolio.com Consolidated Shiga-Toxigenic_Escherichia_coli news from BioPortfolio.com Wed, 10 Feb 2010 02:11:14 GMT en Prostate Cancer Biopsy Effective But Lacks Practice Standardshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034832&HITNO=0&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034832&THISHREF=http://c.moreover.com/click/here.pl%3fz2536001068%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034832&HITNO=0&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034832&THISHREF=http://c.moreover.com/click/here.pl%3fz2536001068%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 201http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038542&HITNO=1&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038542&THISHREF=http://c.moreover.com/click/here.pl%3fz2537650708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038542&HITNO=1&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038542&THISHREF=http://c.moreover.com/click/here.pl%3fz2537650708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMontana's News Station: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037274&HITNO=2&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037274&THISHREF=http://c.moreover.com/click/here.pl%3fz2537007650%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037274&HITNO=2&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037274&THISHREF=http://c.moreover.com/click/here.pl%3fz2537007650%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBoston Business Journal: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037234&HITNO=3&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037234&THISHREF=http://c.moreover.com/click/here.pl%3fz2536982134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037234&HITNO=3&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037234&THISHREF=http://c.moreover.com/click/here.pl%3fz2536982134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiz Journals: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037140&HITNO=4&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037140&THISHREF=http://c.moreover.com/click/here.pl%3fz2536919873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037140&HITNO=4&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037140&THISHREF=http://c.moreover.com/click/here.pl%3fz2536919873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 201http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037109&HITNO=5&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037109&THISHREF=http://c.moreover.com/click/here.pl%3fz2536906696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037109&HITNO=5&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037109&THISHREF=http://c.moreover.com/click/here.pl%3fz2536906696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHouston Chronicle: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 201http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037079&HITNO=6&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037079&THISHREF=http://c.moreover.com/click/here.pl%3fz2536899641%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037079&HITNO=6&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037079&THISHREF=http://c.moreover.com/click/here.pl%3fz2536899641%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037009&HITNO=7&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037009&THISHREF=http://c.moreover.com/click/here.pl%3fz2536859850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037009&HITNO=7&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037009&THISHREF=http://c.moreover.com/click/here.pl%3fz2536859850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036991&HITNO=8&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036991&THISHREF=http://c.moreover.com/click/here.pl%3fz2536858287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036991&HITNO=8&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036991&THISHREF=http://c.moreover.com/click/here.pl%3fz2536858287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036988&HITNO=9&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036988&THISHREF=http://c.moreover.com/click/here.pl%3fz2536856680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036988&HITNO=9&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036988&THISHREF=http://c.moreover.com/click/here.pl%3fz2536856680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Life Sciences: Reports on life sciences findings from P. Schweiger and co-researchers provide new insightshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027352&HITNO=10&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027352&THISHREF=http://c.moreover.com/click/here.pl%3fz2532088658%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027352&HITNO=10&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027352&THISHREF=http://c.moreover.com/click/here.pl%3fz2532088658%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Reports summarize genetics study results from Nihon University, Department of Applied Biological Sciencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028631&HITNO=11&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028631&THISHREF=http://c.moreover.com/click/here.pl%3fz2532790635%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028631&HITNO=11&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028631&THISHREF=http://c.moreover.com/click/here.pl%3fz2532790635%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPoten & Partners: Escherichia coli Therapy: Studies from Zhejiang University, Department of Geriatrics yield new information about Escherichia coli therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024460&HITNO=12&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024460&THISHREF=http://c.moreover.com/click/here.pl%3fz2528906200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024460&HITNO=12&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024460&THISHREF=http://c.moreover.com/click/here.pl%3fz2528906200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Life Sciences: Research in the area of life sciences reported from University of Parishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024463&HITNO=13&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024463&THISHREF=http://c.moreover.com/click/here.pl%3fz2528906329%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024463&HITNO=13&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024463&THISHREF=http://c.moreover.com/click/here.pl%3fz2528906329%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: SAR150640, a selective 3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024127&HITNO=14&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024127&THISHREF=http://c.moreover.com/click/here.pl%3fz2528655891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024127&HITNO=14&MSIZE=109&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Shiga-Toxigenic_Escherichia_coli&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024127&THISHREF=http://c.moreover.com/click/here.pl%3fz2528655891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBritish Journal of Pharmacology: